Suppr超能文献

维生素 D 状态和 VDR 多态性作为分化型甲状腺癌的预后因素。

Vitamin D Status and VDR Polymorphisms as Prognostic Factors in Differentiated Thyroid Carcinoma.

机构信息

"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania;

Research Laboratory, "C. I. Parhon" National Institute of Endocrinology, Bucharest, Romania.

出版信息

In Vivo. 2022 Sep-Oct;36(5):2434-2441. doi: 10.21873/invivo.12977.

Abstract

BACKGROUND/AIM: Vitamin D deficiency and vitamin D receptor (VDR) gene polymorphisms are involved in a variety of biological processes including cell proliferation, apoptosis, and adhesion in malignant tumors. This study investigated whether vitamin D levels and genetic variations of VDR are risk factors for thyroid cancer.

PATIENTS AND METHODS

Patients who underwent surgery for differentiated thyroid carcinoma (n=113) and those with benign thyroid pathology (n=150) were genotyped for VDR gene polymorphisms (ApaI, TaqI, FokI, and BsmI) and their 25(OH)D levels were simultaneously measured. Demographic data and histopathologic reports were also acquired for all patients.

RESULTS

Vitamin D levels were significantly lower in the thyroid cancer group (p=0.03). FokI and TaqI polymorphisms were more frequent in the thyroid cancer patients (p<0.001). Compared to control, the proportion of the FokI Ff genotype was increased (p<0.0006) and the proportion of the TaqI Tt genotype was also higher among patients with thyroid cancer (p<0.0001). The Ff genotype of FokI was also associated with multifocality, invasive pattern, and risk for local metastasis.

CONCLUSION

The VDR gene polymorphism FokI may be associated with the risk of thyroid cancer and its more aggressive forms.

摘要

背景/目的:维生素 D 缺乏和维生素 D 受体(VDR)基因多态性参与多种生物学过程,包括恶性肿瘤中的细胞增殖、凋亡和黏附。本研究探讨了维生素 D 水平和 VDR 基因多态性是否是甲状腺癌的危险因素。

患者和方法

对接受分化型甲状腺癌手术的患者(n=113)和患有良性甲状腺病变的患者(n=150)进行 VDR 基因多态性(ApaI、TaqI、FokI 和 BsmI)的基因分型,并同时测量其 25(OH)D 水平。还为所有患者获取了人口统计学数据和组织病理学报告。

结果

甲状腺癌组的维生素 D 水平显著降低(p=0.03)。FokI 和 TaqI 多态性在甲状腺癌患者中更为常见(p<0.001)。与对照组相比,FokI Ff 基因型的比例增加(p<0.0006),甲状腺癌患者中 TaqI Tt 基因型的比例也更高(p<0.0001)。FokI 的 Ff 基因型也与多灶性、侵袭性模式和局部转移风险相关。

结论

VDR 基因多态性 FokI 可能与甲状腺癌及其侵袭性更强的形式的风险相关。

相似文献

1
Vitamin D Status and VDR Polymorphisms as Prognostic Factors in Differentiated Thyroid Carcinoma.
In Vivo. 2022 Sep-Oct;36(5):2434-2441. doi: 10.21873/invivo.12977.
2
VDR gene FokI polymorphism as a poor prognostic factor for papillary thyroid cancer.
Tumour Biol. 2018 Nov;40(11):1010428318811766. doi: 10.1177/1010428318811766.
3
Vitamin D receptor polymorphisms in differentiated thyroid carcinoma.
Thyroid. 2009 Jun;19(6):623-8. doi: 10.1089/thy.2008.0388.
5
Evaluation of vitamin D receptor gene polymorphisms in patients with differentiated thyroid carcinomas and nodular goiter.
Minerva Endocrinol (Torino). 2021 Sep;46(3):317-324. doi: 10.23736/S2724-6507.20.03160-0. Epub 2020 Aug 3.
6
Association of Vitamin D Deficiency and Vitamin D Receptor Gene Polymorphisms with Type 1 Diabetes Risk: A South Indian Familial Study.
J Clin Res Pediatr Endocrinol. 2024 Mar 11;16(1):21-30. doi: 10.4274/jcrpe.galenos.2023.2022-12-7. Epub 2023 Aug 10.
8
Lower vitamin D levels and VDR FokI variants are associated with susceptibility to sepsis: a hospital-based case-control study.
Biomarkers. 2022 Mar;27(2):188-195. doi: 10.1080/1354750X.2021.2024598. Epub 2022 Jan 9.
10
Lack of association of vitamin D receptor gene polymorphisms/haplotypes in Sjögren's syndrome.
Clin Rheumatol. 2015 Feb;34(2):247-53. doi: 10.1007/s10067-014-2639-6. Epub 2014 May 8.

引用本文的文献

1
Association between vitamin D serum levels and thyroid cancer: a meta-analysis.
Front Endocrinol (Lausanne). 2025 Jul 24;16:1602844. doi: 10.3389/fendo.2025.1602844. eCollection 2025.
2
The Association of Gene Polymorphism and Protein Expression With Histopathological Alterations in Patients With Thyroid Colloid Nodule.
Anal Cell Pathol (Amst). 2025 Feb 18;2025:6796922. doi: 10.1155/ancp/6796922. eCollection 2025.
4
Drug repositioning in thyroid cancer: from point mutations to gene fusions.
Front Oncol. 2024 May 8;14:1407511. doi: 10.3389/fonc.2024.1407511. eCollection 2024.
5
Regulatory and Interacting Partners of PDLIM7 in Thyroid Cancer.
Curr Oncol. 2023 Dec 13;30(12):10450-10462. doi: 10.3390/curroncol30120761.
6
The Role of Genetic Polymorphisms in Differentiated Thyroid Cancer: A 2023 Update.
Biomedicines. 2023 Apr 2;11(4):1075. doi: 10.3390/biomedicines11041075.
7
A Pilot Study of the Association Polymorphisms With Primary Hyperparathyroidism.
In Vivo. 2023 May-Jun;37(3):1111-1116. doi: 10.21873/invivo.13186.
8
Vitamin D-Related Genes and Thyroid Cancer-A Systematic Review.
Int J Mol Sci. 2022 Nov 7;23(21):13661. doi: 10.3390/ijms232113661.

本文引用的文献

1
Vitamin D Receptor Expression and its Clinical Significance in Papillary Thyroid Cancer.
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221089933. doi: 10.1177/15330338221089933.
2
Relationship Between Vitamin D and Thyroid: An Enigma.
Cureus. 2022 Jan 10;14(1):e21069. doi: 10.7759/cureus.21069. eCollection 2022 Jan.
3
The Role of Vitamin D as a Prognostic Marker in Papillary Thyroid Cancer.
Cancers (Basel). 2021 Jul 14;13(14):3516. doi: 10.3390/cancers13143516.
4
The role of vitamin D in head and neck cancer.
Laryngoscope Investig Otolaryngol. 2020 Nov 3;5(6):1079-1088. doi: 10.1002/lio2.469. eCollection 2020 Dec.
6
The role of metabolic setting in predicting the risk of early tumour relapse of differentiated thyroid cancer (DTC).
Eur J Clin Nutr. 2020 Jul;74(7):1038-1046. doi: 10.1038/s41430-020-0671-y. Epub 2020 Jun 9.
7
Rising Incidence and Incidence-Based Mortality of Thyroid Cancer in California, 2000-2017.
J Clin Endocrinol Metab. 2020 Jun 1;105(6). doi: 10.1210/clinem/dgaa121.
9
Vitamin D receptor expression in invasive breast tumors and breast cancer survival.
Breast Cancer Res. 2019 Jul 29;21(1):84. doi: 10.1186/s13058-019-1169-1.
10
Association of Vitamin D Pathway Genetic Variation and Thyroid Cancer.
Genes (Basel). 2019 Jul 28;10(8):572. doi: 10.3390/genes10080572.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验